[HTML][HTML] The roles of KLHL family members in human cancers
G Ye, J Wang, W Yang, J Li, M Ye… - American Journal of …, 2022 - ncbi.nlm.nih.gov
The Kelch-like (KLHL) family members consist of three domains: bric-a-brac, tramtrack,
broad complex/poxvirus and zinc finger domain, BACK domain and Kelch domain, which …
broad complex/poxvirus and zinc finger domain, BACK domain and Kelch domain, which …
Differential expression of LncRNA in bladder cancer development
L Spirito, R Maturi, SC Credendino, C Manfredi… - Diagnostics, 2023 - mdpi.com
Bladder cancer (BC) is the tenth most common cancer, with urothelial carcinoma
representing about 90% of all BC, including neoplasms and carcinomas of different grades …
representing about 90% of all BC, including neoplasms and carcinomas of different grades …
[HTML][HTML] Characterization of KLHL14 anti-oncogenic action in malignant mesothelioma
Malignant mesothelioma (MM) is a very aggressive neoplasia with a short life expectancy
and limited therapeutic options. Thus, the identification of novel molecular targets is a matter …
and limited therapeutic options. Thus, the identification of novel molecular targets is a matter …
KLHL14 is a tumor suppressor downregulated in undifferentiated thyroid cancer
M Esposito, A Migliaccio, SC Credendino… - Cell Death …, 2024 - nature.com
KLHL14 is a substrate-binding subunit of Cullin-RING ligase 3 ubiquitin ligase complex,
highly enriched in thyroid since early embryonic development, together with its antisense …
highly enriched in thyroid since early embryonic development, together with its antisense …
KLHL14 and E Cadherin Nuclear Co-expression as Predicting Factor of Nonfunctioning Pituitary Adenomas Invasiveness: Preliminary study
J Berardinelli, V Russo, A Canciello, O Giacinto… - 2024 - researchsquare.com
Purpose: Novel diagnostic and therapeutic approaches are needed to improve the clinical
management of nonfunctioning pituitary adenomas (NFPA). Here, the expression of two …
management of nonfunctioning pituitary adenomas (NFPA). Here, the expression of two …
[PDF][PDF] Differential Expression of LncRNA in Bladder Cancer Development. Diagnostics 2023, 13, 1745
L Spirito, R Maturi, SC Credendino, C Manfredi… - 2023 - researchgate.net
Bladder cancer (BC) is the tenth most common cancer, with urothelial carcinoma
representing about 90% of all BC, including neoplasms and carcinomas of different grades …
representing about 90% of all BC, including neoplasms and carcinomas of different grades …